AGP Pharmaceuticals: Major
Health Technology
Mkt Cap
52.1B
P/E (TTM)
14.18
EPS
13.34
ROE
24.55%
Div Yield
4.30%
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Return on Equity (ROE) | 25.87% | 21.49% | 14.24% | 15.52% | 19.53% | |
| Return on Assets (ROA) | 12.15% | 9.31% | 7.03% | 9.99% | 13.93% | |
| Return on Invested Capital | 17.68% | 12.70% | 9.36% | 12.79% | 16.84% | |
| Gross Margin | 58.06% | 56.61% | 52.21% | 49.11% | 52.42% | |
| Operating Margin | 27.48% | 28.21% | 23.03% | 20.87% | 27.68% | |
| EBITDA Margin | 29.19% | 29.73% | 24.73% | 22.61% | 29.59% | |
| Net Margin | 12.93% | 10.66% | 8.35% | 10.86% | 18.75% | |
| Pre-Tax Margin | 22.58% | 17.62% | 13.97% | 16.88% | 24.77% | |
| Liquidity | ||||||
| Current Ratio | 1.01 | 1.08 | 1.16 | 1.30 | 1.62 | |
| Quick Ratio | 0.46 | 0.43 | 0.56 | 0.57 | 0.84 | |
| Leverage | ||||||
| Debt / Equity | 0.65 | 0.81 | 1.09 | 0.31 | 0.32 | |
| Debt / Assets | 0.31 | 0.37 | 0.45 | 0.20 | 0.21 | |
| LT Debt / Equity | 0.37 | 0.57 | 0.84 | 0.18 | 0.25 | |
| LT Debt / Assets | 0.18 | 0.26 | 0.34 | 0.11 | 0.17 | |
| Net Debt | 8.65B | 9.96B | 11.42B | 2.82B | 2.37B | |
| Total Debt | 10.04B | 10.88B | 12.45B | 3.29B | 3.09B | |
| Efficiency | ||||||
| Asset Turnover | 0.94 | 0.87 | 0.84 | 0.92 | 0.74 | |
| Inventory Turnover | 2.59 | 2.72 | 2.98 | 3.53 | 3.09 | |
| Per Share | ||||||
| Book Value Per Share | 55.24 | 47.90 | 40.86 | 37.67 | 34.56 | |
| Tangible Book Per Share | -7.28 | -14.65 | -21.75 | 5.86 | 2.75 | |
| Cash Per Share | 4.94 | 3.28 | 3.67 | 1.67 | 2.56 | |
| Total Debt Per Share | 35.84 | 38.85 | 44.46 | 11.73 | 11.04 | |
| Working Capital Per Share | 0.43 | 1.91 | 3.34 | 3.69 | 4.71 | |
| Shares & Market | ||||||
| Total Shares Outstanding | 280,000,000 | 280,000,000 | 280,000,000 | 280,000,000 | 280,000,000 | |
| Market Cap | 56.88B | 47.63B | 19.69B | 18.20B | 27.16B | |
| Enterprise Value | 67.19B | 58.74B | 32.03B | 21.60B | 30.01B | |
| Employees | 1,679 | 1,574 | 1,574 | 1,428 | 1,375 | |
| Shareholders | 5,078 | 5,078 | 5,078 | 5,078 | 5,078 | |